Clinical Trial Update: Atezolizumab in Combination With Bevacizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial of atezolizumab plus bevacizumab in unresectable mucosal melanoma completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucosal Melanoma

Drugs mentioned

• Avastin (bevacizumab)
• Tecentriq (atezolizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2024-10-24